Merck & Co Inc (NYSE: MRK ) is in advanced talks to acquire Seagen Inc (NASDAQ: SGEN ), and an agreement on a purchase is expected in the next few weeks, Wall Street Journal reported citing people familiar with the matter.
The potential deal could be worth roughly $40 billion or more.
Related: Full story available on Benzinga.com